NEW YORK – Aspira Women's Health said Thursday that is has entered a collaborative research agreement with Baylor Genetics to codevelop an early detection test for ovarian cancer.
Austin, Texas-based Aspira said it will bring its experience in recruitment of patient samples and assay development to the collaboration.